Halme M - Search Results

1

Interferons combined with chemotherapy in the treatment of stage III-IV non-small cell lung cancer--a randomised study.

Halme M, Maasilta PK, Pyrhönen SO, Mattson KV. Halme M, et al. Eur J Cancer. 1994;30A(1):11-5. doi: 10.1016/s0959-8049(05)80009-7. Eur J Cancer. 1994. PMID: 8142151 Clinical Trial.

2

Natural alpha-interferon in combination with hyperfractionated radiotherapy in the treatment of non-small cell lung cancer.

Maasilta P, Holsti LR, Halme M, Kivisaari L, Cantell K, Mattson K. Maasilta P, et al. Among authors: halme m. Int J Radiat Oncol Biol Phys. 1992;23(4):863-8. doi: 10.1016/0360-3016(92)90660-a. Int J Radiat Oncol Biol Phys. 1992. PMID: 1319982 Clinical Trial.

3

Inhaled recombinant interferon gamma in patients with lung cancer: pharmacokinetics and effects on chemiluminescence responses of alveolar macrophages and peripheral blood neutrophils and monocytes.

Halme M, Maasilta P, Repo H, Ristola M, Taskinen E, Mattson K, Cantell K. Halme M, et al. Int J Radiat Oncol Biol Phys. 1995 Jan 1;31(1):93-101. doi: 10.1016/0360-3016(94)00365-R. Int J Radiat Oncol Biol Phys. 1995. PMID: 7995773 Clinical Trial.

4

Pharmacokinetics and toxicity of inhaled human natural interferon-beta in patients with lung cancer.

Halme M, Maasilta P, Mattson K, Cantell K. Halme M, et al. Respiration. 1994;61(2):105-7. doi: 10.1159/000196316. Respiration. 1994. PMID: 8008985

5

Subcutaneously administered recombinant interferon-gamma in humans: pharmacokinetics and effects on chemiluminescence responses of alveolar macrophages, blood neutrophils, and monocytes.

Halme M, Maasilta P, Repo H, Leirisalo-Repo M, Taskinen E, Mattson K, Cantell K. Halme M, et al. J Immunother Emphasis Tumor Immunol. 1994 May;15(4):283-91. J Immunother Emphasis Tumor Immunol. 1994. PMID: 8061901 Clinical Trial.

6

Interferon-alpha and interferon-gamma combined with chemotherapy: in vitro sensitivity studies in non-small cell lung cancer cell lines.

Hand A, Pelin K, Halme M, Ekman A, Mattson M, Vallas M, Mattson K, Linnainmaa K, Husgafvel-Pursiainen K. Hand A, et al. Among authors: halme m. Anticancer Drugs. 1993 Jun;4(3):365-8. Anticancer Drugs. 1993. PMID: 8395259

7

A phase II trial of docetaxel in advanced non-small cell lung cancer.

Saarinen A, Jekunen A, Halme M, Pyrhönen S, Tamminen K, Boyer R, Roubille N, Mattson K. Saarinen A, et al. Among authors: halme m. Anticancer Drugs. 1996 Nov;7(8):890-2. doi: 10.1097/00001813-199611000-00012. Anticancer Drugs. 1996. PMID: 8991195 Clinical Trial.

8

Interferon maintenance therapy for small cell lung cancer: improvement in long-term survival.

Mattson K, Niiranen A, Ruotsalainen T, Maasilta P, Halme M, Pyrhönen S, Kajanti M, Mäntylä M, Tamminen K, Jekunen A, Sarna S, Cantell K. Mattson K, et al. Among authors: halme m. J Interferon Cytokine Res. 1997 Feb;17(2):103-5. doi: 10.1089/jir.1997.17.103. J Interferon Cytokine Res. 1997. PMID: 9058316 Clinical Trial.

9

Phase II study of weekly gemcitabine in advanced non-small cell lung cancer.

Halme M, Jekunen A, Tamminen K, Mattson K. Halme M, et al. Respir Med. 1997 Aug;91(7):423-6. doi: 10.1016/s0954-6111(97)90257-2. Respir Med. 1997. PMID: 9327044 Free article. Clinical Trial.

10

Tumour response and radiation-induced lung injury in patients with recurrent small cell lung cancer treated with radiotherapy and concomitant interferon-alpha.

Halme M, Hallman M, Ruotsalainen T, Piilonen A, Taskinen E, Pekonen M, Maasilta P, Mattson K. Halme M, et al. Lung Cancer. 1999 Jan;23(1):39-52. doi: 10.1016/s0169-5002(98)00092-0. Lung Cancer. 1999. PMID: 10100145 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

78 results

Search Page

Filters